EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15420823

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon 53 skipping are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOPHARMA CREDIT PLC51 NEW NORTH ROAD C/O BEAUFORT HOUSE EXETER EX4 4EP

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BESTWICK, Richard K Corvallis, US 49 820
FRANK, Diane Elizabeth Seattle, US 23 316

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation